recent presentations
 

Molecular Epidemiology of Chronic disease and the Exposome
H. Gmuender
Institute for Risk Assessment Sciences, Utrecht, Netherland
Biomarker Detection Using 'omics Approaches

Eurotox 2006, 43nd Congress of the European Societies of Toxicology, Dubrovnik, Croatia
H. Gmuender, M. Wendt, T. Freeman and J. König, Genedata AG
Toxicogenomics and biomarker discovery for the prediction of long term toxicity

Biomarker Discovery, Workshop organized by Genedata, Basel, 2006
H. Gmuender, Genedata AG
In silico toxicity evaluation and mode of action prediction based on reference compendia

Spring Symposium of Korean Society of Toxicology, Alternative Toxicology, Daegu, Korea, 2006
H. Gmuender, Genedata AG

In silico toxicity evaluation and mode of action prediction based on reference compendia

CHI's Beyond Genome, San Francisco, 2005
Thomas Steger-Hartmann, PhD, Head of Laboratory Diagnostics, Genetic and Ecotoxicology
Schering AG, Berlin
Hans Gmuender, PhD, Head of Scientific Consulting, Genedata AG, Switzerland
Application of Systems Biology in Toxicology - Past Experiences, Present Applications and Future Perspectives

Eurotox 2005, 42nd Congress of the European Societies of Toxicology, Cracow, Poland, 2005
H. Gmuender and A. Hohn, Genedata AG

Toxicogenomics and biomarker discovery for the prediction of long term toxicity

CHI's Intelligent Drug Discovery and Development, Philadelphia, 2003
H. Gmuender, Genedata AG
Application of Microarrays to Toxicity Studies

Drug Discovery Technology, Stuttgart, 2002
Jutta Heim, Arndt Brachat, Novartis Pharma Research
Hans Gmünder, Genedata AG
Expression Profiling in Drug Discovery

home